Advances and new technologies in the treatment of burn injury

Adv Drug Deliv Rev. 2018 Jan 1:123:1-2. doi: 10.1016/j.addr.2017.11.011.

Authors

Yiwei Wang¹, Peter K M Maitz²

Affiliations

¹ Burns Research Group, ANZAC Research Institute, Concord Repatriation General Hospital, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: yiweiwang@anzac.edu.au.
² Burns Research Group, ANZAC Research Institute, Burns and Reconstructive Surgery Unit, Concord Repatriation General Hospital, Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: peter.maitz@sydney.edu.au.

PMID: 29273168
DOI: 10.1016/j.addr.2017.11.011

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antifungal Agents / therapeutic use*
Burns / therapy*
Humans
Stem Cells*
Tissue Engineering

Substances

Anti-Bacterial Agents
Antifungal Agents